Biofluid Research on Age-Related or Inherited Neurodegeneration
University of Pennsylvania · with University of Pennsylvania Institute on Aging, National Institute on Aging (NIA) · NCT07798700
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 1
- Study start
- December 12, 2025
- Record last updated
- September 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The aim of this study is to contribute to and continue to sustain a repository of blood samples, nucleic acid (DNA and/or RNA) samples, family history information, and other demographic information from individuals with age-related neurodegenerative conditions, or their family members who may or may not be at risk for similar conditions. This study will continue to further expand research into the molecular and genetic basis of these diseases and their risk factors.
Conditions: Frontotemporal Degeneration (FTD); ALS (Amyotrophic Lateral Sclerosis); Primary Progressive Aphasia (PPA); Familial Frontotemporal Lobar Degeneration (fFTLD); Fronto-temporal Lobar Dementia; Dementia With Lewy Bodies (DLB); Cortical Basal Syndrome (CBS); Alzheimer's Disease (AD); Progressive Supranuclear Palsy(PSP); Parkinson's Disease (PD); Parkinson's Disease Dementia (PDD); Limbic-predominant Age-related TDP-43 Encephalopathy (LATE); Posterior Cortical Atrophy (PCA); Primary Lateral Sclerosis (PLS); Primary Muscular Atrophy (PMA)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- People with a clinical diagnosis of a neurodegenerative disease including, but not limited to Alzheimer's disease (AD), Parkinson's disease (PD), Parkinson's disease dementia (PDD), dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), progressive supranuclear palsy (PSP), primary progressive aphasia (PPA), limbic-predominant age-related TDP-43 encephalopathy (LATE), corticobasal syndrome (CBS), posterior cortical atrophy (PCA), primary lateral sclerosis (PLS), primary muscular atrophy (PMA), or individuals with a suspected neurodegenerative dementia and/or movement disorder of unknown etiology will be considered for enrollment
- Family Members of individuals who meet the criteria of group 1, who are people who may or may not be at risk for a similar neurodegenerative disease, who may or may not be symptomatic, and who may or may not have known or unknown genetic risk.
- People with no known neurological disease who will provide control data.
Exclusion Criteria
- Anyone who is under the age of 18.
- Anyone with a condition or in a situation which, in the investigator's opinion, could confound the study findings or may interfere significantly with a person's participation, including but not limited to neurological, psychological, and other medical conditions (such as cardiac, neurosurgical, infectious conditions).
Recruiting US locations
University of Pennsylvania
Philadelphia, PA 19104
Site contact: Cara Joyce, MPH · 267-271-0740 · cara.joyce@pennmedicine.upenn.edu
Study contacts (from the official record)
- Cara Joyce, MPH · 267-271-0740 · cara.joyce@pennmedicine.upenn.edu
- Emily Xie · 16109553114 · emily.xie@pennmedicine.upenn.edu
Similar studies in Pennsylvania
All neurology studies in Pennsylvania →- RecruitingPhase 1/Phase 2Overnight stay mentioned
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Vector Y Therapeutics
- Location
- Philadelphia, PA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
University of Pennsylvania
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingHealthy volunteersEarly Phase 1
Localizing Epileptic Networks Using MRI and iEEG
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 40–80